Morados, Ricky F.
HRN: 29-08-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/31/2026
06/07/2026
IV
600MG
Q6HRS
AVULSED WOUND
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines